DLG5
Basic information
Region (hg38): 10:77790791-77926755
Links
Phenotypes
GenCC
Source:
- ciliopathy (Limited), mode of inheritance: AD
- ciliopathy (Limited), mode of inheritance: AR
- congenital anomaly of kidney and urinary tract (Limited), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Yuksel-Vogel-Bauser syndrome | AR | Cardiovascular; Renal | Among other findings, individuals have been described with congenital cardiovascular and renal anomalies (such as salt wasting that required supplementation), and awareness may allow early identification and management | Cardiovascular; Craniofacial; Musculoskeletal; Neurologic; Renal | 30791088; 32631816 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the DLG5 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 17 | |||||
missense | 108 | 12 | 124 | |||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 2 | 2 | ||||
non coding | 2 | |||||
Total | 1 | 0 | 108 | 21 | 14 |
Variants in DLG5
This is a list of pathogenic ClinVar variants found in the DLG5 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
10-77792491-C-G | not specified | Uncertain significance (Oct 03, 2022) | ||
10-77792515-G-C | not specified | Uncertain significance (Jun 07, 2024) | ||
10-77792526-C-T | not specified | Uncertain significance (Jan 08, 2024) | ||
10-77793998-G-A | Likely benign (May 16, 2018) | |||
10-77794017-A-G | not specified | Uncertain significance (Apr 27, 2024) | ||
10-77794049-G-C | not specified | Uncertain significance (Feb 27, 2023) | ||
10-77794057-C-T | Benign (Dec 31, 2019) | |||
10-77794076-T-A | not specified | Uncertain significance (Dec 20, 2023) | ||
10-77794873-T-C | not specified | Uncertain significance (Mar 31, 2024) | ||
10-77794909-T-G | Uncertain significance (-) | |||
10-77794922-T-C | not specified | Uncertain significance (Jun 04, 2024) | ||
10-77794935-A-G | Likely benign (Sep 19, 2018) | |||
10-77796090-C-T | not specified | Uncertain significance (Oct 03, 2022) | ||
10-77796111-C-T | not specified | Uncertain significance (Apr 23, 2024) | ||
10-77796112-G-A | Likely benign (May 21, 2018) | |||
10-77796120-G-A | not specified | Uncertain significance (Sep 26, 2022) | ||
10-77796146-T-C | not specified | Uncertain significance (Nov 10, 2022) | ||
10-77796486-T-A | not specified | Uncertain significance (Mar 28, 2024) | ||
10-77796543-A-G | Benign (Dec 31, 2019) | |||
10-77796547-C-T | Benign (Dec 31, 2019) | |||
10-77805745-T-C | not specified | Uncertain significance (Apr 01, 2024) | ||
10-77805746-G-C | not specified | Uncertain significance (Jan 31, 2024) | ||
10-77805760-C-T | not specified | Uncertain significance (Apr 13, 2022) | ||
10-77805761-G-A | not specified | Uncertain significance (Apr 08, 2022) | ||
10-77805784-G-A | not specified | Uncertain significance (Sep 14, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
DLG5 | protein_coding | protein_coding | ENST00000372391 | 32 | 135830 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.999 | 0.000523 | 125720 | 0 | 28 | 125748 | 0.000111 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.59 | 919 | 1.17e+3 | 0.787 | 0.0000750 | 12497 |
Missense in Polyphen | 379 | 607.02 | 0.62436 | 6572 | ||
Synonymous | -0.802 | 524 | 501 | 1.05 | 0.0000332 | 3859 |
Loss of Function | 7.05 | 14 | 83.5 | 0.168 | 0.00000421 | 984 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000210 | 0.000210 |
Ashkenazi Jewish | 0.0000999 | 0.0000992 |
East Asian | 0.000274 | 0.000217 |
Finnish | 0.000241 | 0.000231 |
European (Non-Finnish) | 0.0000977 | 0.0000967 |
Middle Eastern | 0.000274 | 0.000217 |
South Asian | 0.0000656 | 0.0000653 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Acts as a regulator of the Hippo signaling pathway (PubMed:28087714, PubMed:28169360). Negatively regulates the Hippo signaling pathway by mediating the interaction of MARK3 with STK3/4, bringing them together to promote MARK3-dependent hyperphosphorylation and inactivation of STK3 kinase activity toward LATS1 (PubMed:28087714). Positively regulates the Hippo signaling pathway by mediating the interaction of SCRIB with STK4/MST1 and LATS1 which is important for the activation of the Hippo signaling pathway. Involved in regulating cell proliferation, maintenance of epithelial polarity, epithelial- mesenchymal transition (EMT), cell migration and invasion (PubMed:28169360). Plays an important role in dendritic spine formation and synaptogenesis in cortical neurons; regulates synaptogenesis by enhancing the cell surface localization of N- cadherin. Acts as a positive regulator of hedgehog (Hh) signaling pathway. Plays a critical role in the early point of the SMO activity cycle by interacting with SMO at the ciliary base to induce the accumulation of KIF7 and GLI2 at the ciliary tip for GLI2 activation (By similarity). {ECO:0000250|UniProtKB:E9Q9R9, ECO:0000269|PubMed:28087714, ECO:0000269|PubMed:28169360}.;
Recessive Scores
- pRec
- 0.165
Intolerance Scores
- loftool
- 0.124
- rvis_EVS
- -2.37
- rvis_percentile_EVS
- 1.13
Haploinsufficiency Scores
- pHI
- 0.279
- hipred
- Y
- hipred_score
- 0.685
- ghis
- 0.564
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- H
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.654
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Dlg5
- Phenotype
- mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); renal/urinary system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); growth/size/body region phenotype; cellular phenotype; homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- epithelial to mesenchymal transition;signal transduction;negative regulation of cell population proliferation;maintenance of cell polarity;negative regulation of cell migration;polarized epithelial cell differentiation;midbrain development;negative regulation of hippo signaling;positive regulation of hippo signaling;intracellular signal transduction;negative regulation of T cell proliferation;regulation of apoptotic process;apical protein localization;zonula adherens assembly;establishment or maintenance of epithelial cell apical/basal polarity;positive regulation of smoothened signaling pathway;positive regulation of synapse assembly;epithelial tube branching involved in lung morphogenesis;positive regulation of dendritic spine development;protein-containing complex assembly;protein localization to adherens junction;metanephric collecting duct development;cell-cell adhesion
- Cellular component
- cytoplasm;plasma membrane;cell-cell adherens junction;postsynaptic density;cell junction;ciliary basal body;postsynaptic membrane
- Molecular function
- protein binding;beta-catenin binding;cytoskeletal protein binding;receptor signaling complex scaffold activity